Boston Scientific Corp's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Research-and-Development" stands at 1.94 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
Boston Scientific Corp's third quarter result of 0.514 Billion USD for the item "Research and Development" represents a decrease of -2.28 percent compared to it's second quarter result.
Also, Boston Scientific Corp's third quarter result of 0.514 Billion USD for the item "Research and Development" represents an increase of 26.29 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Boston Scientific Corp's third quarter result of 1.94 Billion USD for the item "Research and Development" represents an increase of 5.83 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 27.91 percent compared to the value the year prior.
The 1 year change in percent is 27.91.
The 3 year change in percent is 47.98.
The 5 year change in percent is 66.64.
The 10 year change in percent is 131.03.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Research and Development | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Research and Development | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Research and Development | 172,241,486,586.05 |
![]() | Danaher Corporation - Research and Development | 162,006,663,168.00 |
![]() | Stryker Corporation - Research and Development | 139,209,850,880.00 |